Bisphosphonate-associated osteonecrosis of the jaw: a literature review and clinical practice guidelines.
Background. Osteonecrosis of the jaw has recently been reported as a possible adverse drug effect from bisphosphonate therapy. Reports are coming from all over the world. Norvartis, a pharmaceutical manufacturer of two implicated drug products, has notified dentists in the United States and made rec...
| Published in: | Journal of Dental Hygiene Vol. 80; no. 3; pp. 12p - 13 |
|---|---|
| Main Author: | |
| Format: | pictorial practice guidelines review Journal Article |
| Published: |
American Dental Hygienists Association
Summer2006
|
| Online Access: | View this record in EBSCOhost |